Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Curis, Inc. to Present at the 2019 BIO CEO & Investor Conference

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive...

CRIS : 1.16 (+5.45%)
Has Curis (CRIS) Outpaced Other Medical Stocks This Year?

Is (CRIS) Outperforming Other Medical Stocks This Year?

CRIS : 1.16 (+5.45%)
Is Curis (CRIS) Outperforming Other Medical Stocks This Year?

Is (CRIS) Outperforming Other Medical Stocks This Year?

CRIS : 1.16 (+5.45%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on January 2, 2019, the independent Compensation...

CRIS : 1.16 (+5.45%)
Aduro BioTech (ADRO) Looks Good: Stock Adds 7.7% in Session

Aduro BioTech (ADRO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

CRIS : 1.16 (+5.45%)
ADRO : 3.85 (-0.77%)
Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dicerna Pharmaceuticals, Inc....

DRNA : 10.41 (-3.16%)
ADSK : 160.03 (-0.40%)
CRIS : 1.16 (+5.45%)
EGRX : 42.72 (+2.10%)
SLF : 37.68 (+1.56%)
ACN : 159.84 (+0.23%)
Curis to Present at the 60th Annual Meeting of the American Society of Hematology

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced three upcoming poster presentations...

CRIS : 1.16 (+5.45%)
Curis to Present at 33rd Society for Immunotherapy of Cancer Annual Meeting and Cowen IO NEXT Summit

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced upcoming presentations at the...

CRIS : 1.16 (+5.45%)
Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of 29.03% and 19.62%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 1.16 (+5.45%)
Curis: 3Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Thursday reported a loss of $7.2 million in its third quarter.

CRIS : 1.16 (+5.45%)
Curis to Release Third Quarter Financial Results and Hold Conference Call on November 1, 2018

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced that the Company will release...

CRIS : 1.16 (+5.45%)
Investor Expectations to Drive Momentum within Ormat Technologies, The Andersons, Freshpet, Curis, Ultra Clean, and Edge Therapeutics -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ormat Technologies, Inc....

ANDE : 37.34 (+1.72%)
FRPT : 39.50 (-1.25%)
CRIS : 1.16 (+5.45%)
UCTT : 12.87 (+4.21%)
EDGE : 0.39 (-2.50%)
ORA : 57.64 (+0.16%)
Is a Beat in Store for Vertex (VRTX) This Earnings Season?

On Vertex' (VRTX) third-quarter 2018 earnings call, investor focus will be on the sales figures of its newest CF drug, Symdeko.

CRSP : 32.06 (-1.08%)
CRIS : 1.16 (+5.45%)
VRTX : 187.39 (+0.28%)
AMGN : 187.08 (+0.06%)
Curis (CRIS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Curis, Inc. (CRIS).

CRIS : 1.16 (+5.45%)
Curis: 1Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Thursday reported a loss of $10.7 million in its first quarter.

CRIS : 1.16 (+5.45%)
Curis Reports First Quarter 2018 Financial Results

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today reported its financial results...

CRIS : 1.16 (+5.45%)
Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company...

CRIS : 1.16 (+5.45%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today announced that...

CRIS : 1.16 (+5.45%)
Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atrion Corporation (NASDAQ:ATRI),...

FF : 19.07 (+0.69%)
UTMD : 90.11 (-0.76%)
OPNT : 14.91 (-5.69%)
ATRI : 809.00 (+1.01%)
CRIS : 1.16 (+5.45%)
ICD : 3.52 (-1.40%)
Biotech Stocks' Research Reports Released on CorMedix, Curis, Cyclacel Pharma, and Cymabay Therapeutics

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CRMD, CRIS, CYCC, and CBAY which can be accessed for free by signing up to www.wallstequities.com/registration....

CRIS : 1.16 (+5.45%)
CBAY : 9.86 (-4.18%)
CRMD : 1.87 (-1.58%)
CYCC : 0.83 (+5.06%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX -0.38
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar